A detailed history of Group One Trading, L.P. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,985 shares of ATAI stock, worth $2,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,985
Holding current value
$2,362
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.16 - $1.64 $2,302 - $3,255
1,985 New
1,985 $2,000
Q4 2022

Feb 09, 2023

BUY
$2.38 - $3.55 $21,850 - $32,592
9,181 New
9,181 $24,000
Q2 2022

Aug 11, 2022

SELL
$3.03 - $5.32 $1.36 Million - $2.39 Million
-449,742 Reduced 98.95%
4,795 $17,000
Q1 2022

May 12, 2022

SELL
$4.66 - $7.66 $18,691 - $30,724
-4,011 Reduced 0.87%
454,537 $2.31 Million
Q4 2021

Feb 11, 2022

BUY
$6.82 - $17.8 $3.13 Million - $8.16 Million
458,548 New
458,548 $3.5 Million

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.